Latest news with #CUD
Mid East Info
4 days ago
- Health
- Mid East Info
Canadian University Dubai to lead three DFF funded projects to advance healthcare innovation - Middle East Business News and Information
Projects to position UAE at the forefront of technology-driven solutions in the healthcare sector Researchers from the Canadian University Dubai (CUD) have been awarded three separate grants from the Dubai Future Foundation (DFF) Research, Development, and Innovation (RDI) Program to advance the application of technologies to improve the health of people in the UAE. CUD faculty will be leading each of the projects, that will develop tools to improve health outcomes and position the UAE at the forefront of technology-driven healthcare solutions. The university's School of Engineering, Applied Science and Technology has secured two grants to support projects aimed at advancing technologies that support diagnostic and therapeutic aspects of healthcare. Led by CUD's Prof. Firuz Kamalov, in collaboration with the Abu Dhabi School of Management and the University of Huddersfield, a team of researchers will pioneer an Explainable Artificial Intelligence system to support the early detection of dementia and to develop an understanding of its potential progression. The project has the capacity to deliver a major step forward in transforming dementia care through AI-driven innovation that can deliver earlier diagnosis to improve patient treatment, guide clinical decisions, and offer vital support to families. Meanwhile, another project in the same School of Engineering Applied Science and Technology is led by Associate Professor, Dr. Haythem El-Messiry, in partnership with researchers from Shandong University and the Mohamed bin Zayed University of Artificial Intelligence. This project will harness the power of Volume Electron Microscopy (VEM) to enhance biological research capabilities. VEM involves a group of electron microscopy techniques for revealing the 3D ultrastructure of organisms at nanometer resolution. The technology is heralded as a revolutionary advancement in imaging to unravel biological complexity at scale, supporting the progression of research in health sciences. This project aims to develop a fast, robust, and high-precision VEM image processing workflow which can achieve high-throughput and high-resolution large-scale biological 3D structure analysis to effectively bridge the gap between cell biology and tissue biology analysis. A third project in the university's School of Health Sciences and Psychology will embark on a pioneering project to establish a Health Technology Assessment (HTA) System in the UAE, to improve evidence-based decision-making in healthcare. Aiming to digitize health systems and promote multi-sectoral and multidisciplinary approaches, the project will integrate AI and web-based platforms, to enable more informed decisions about the value and reimbursement of health technologies. Led by CUD Assistant Professor, Dr. Mohammed AlKhaldi, the research team will also include CUD Associate Professor, Dr. Wissam Ghash, along with collaborators from McGill University, Canada and University of Bonn, Germany. Each of the projects aims to contribute to the UAE's strategic vision to be a world leader in healthcare and wellbeing. Speaking about the awards, CUD Provost, Dr. Adam Fenech said, 'These grants recognize CUD's leading role in health research and innovation in the UAE and wider region. With the support of Dubai Future Foundation and our institutional partners, we are tackling critical issues in global healthcare. These projects have the potential to establish the UAE as the benchmark for innovations that have impact on a global scale.' ———- About Canadian University Dubai Established in 2006, Canadian University Dubai (CUD) is a higher education institution located in City Walk, Dubai, United Arab Emirates (UAE). The university is the #1 ranking University in Dubai according to the QS World University Rankings 2025. CUD is a diverse and dynamic institution, with over 120 student nationalities. With a reputation for academic excellence, the university offers more than 30 specialized majors, concentrations, and focus area pathways, through over 25 accredited undergraduate and graduate degree programs. The curriculum is Canadian-inspired and serves as a gateway for students to pursue higher education, research, entrepreneurship and employment opportunities in Canada.
Zawya
11-07-2025
- Business
- Zawya
CUD introduces new AI program to advance global leadership in artificial intelligence
Dubai, UAE: Canadian University Dubai (CUD) has announced the launch of a Bachelor of Science in Artificial Intelligence (BScAI) program, to equip students with skills to succeed in one of the fastest growing industries in the global economy. Delivered through the School of Engineering, Applied Science and Technology, the program aims to contribute to the national strategy to transform the UAE into a world-leader in AI. Designed to meet the surging demand for skilled professionals in the fast-evolving tech landscape, the BScAI program blends a rigorous academic foundation with cutting-edge practical training. The curriculum begins with core principles in mathematics and computer science, then progresses into advanced AI domains such as machine learning, neural networks, and intelligent systems, empowering students with hands-on experience in computer vision, natural language processing, and autonomous decision-making. Beyond the technical skills, the program emphasizes critical soft skills and ethical leadership, integrating courses in communication, ethical AI, and entrepreneurship to produce graduates who are not just highly proficient AI specialists, but also responsible thinkers ready to address the societal, ethical, and business challenges of an AI-driven future With a focus on building expertise and employability, the program allows students to choose from a wide range of elective courses in specialized areas such as speech recognition, digital vision, and multilingual AI, enabling them to explore and focus on their personal interests. As part of the program, students will complete a real-world internship and a final-year AI project, giving them valuable hands-on experience prior to graduation. The program launch is set in the context of the UAE National Strategy for Artificial Intelligence 2031, which aims to position the UAE as a global leader in the field of AI. The BScAI will support the strategy by building a new generation of regional talent that is equipped to enter jobs enabled by AI, and to lead in a rapidly evolving technological landscape. Speaking about the opportunities for graduates of the BScAI, Dr. Tamer Mohamed, Chair of the Department of Computer Engineering and Computational Science, said, 'We have built this program to empower students with the tools to shape the future. Whether they want to create new technologies, solve global challenges, or launch their own startups, this degree opens the door to endless possibilities.' Dr. Sherif Moussa, Dean of the School of Engineering, Applied Science and Technology, added, 'This launch reflects our vision to provide education that's not just relevant, but also transformative. As Dubai is rapidly becoming a global center for AI, we are proud to contribute to building professional capacity in this important economic sector. We look forward to our students leading the way in harnessing AI technology across industries in the UAE.' The Bachelor of Science in Artificial Intelligence is now open to applications for Fall 2025. About Canadian University Dubai Established in 2006, Canadian University Dubai (CUD) is a higher education institution located in City Walk, Dubai, United Arab Emirates (UAE). The university is the #1 ranking University in Dubai according to the QS World University Rankings 2025. CUD is a diverse and dynamic institution, with over 120 student nationalities. With a reputation for academic excellence, the university offers more than 30 specialized majors, concentrations, and focus area pathways, through over 25 accredited undergraduate and graduate degree programs. The curriculum is Canadian-inspired and serves as a gateway for students to pursue higher education, research, entrepreneurship and employment opportunities in Canada.
Mid East Info
02-07-2025
- Business
- Mid East Info
Canadian University Dubai to Host Global Cumulus 2026: A Future-Defining Summit in Regenerative Design
Summit to explore visionary approaches in regenerative and circular design Canadian University Dubai (CUD) has been officially selected to host the prestigious 2026 Cumulus Conference, one of the world's most influential gatherings of art, design, and media education. Spearheaded by the University's School of Architecture and Interior Design, the five-day global summit will take place in November 2026 under the theme: 'Design(ed) Visions of Tomorrow | The Future of Human Condition'. Held in the context of climate disruption, social uncertainty, and rapid technological advancement, the 2026 Cumulus Dubai Conference will bring together international designers, educators, and researchers to reimagine the role of design in shaping regenerative, inclusive, and ethically driven futures. The summit will explore how design can serve as a catalyst for rethinking human life and living systems across physical, social, cultural, and ecological dimensions. The Conference program will feature an interdisciplinary series of high-level panel discussions, exhibitions, hands-on workshops, and collaborative think tanks spanning architecture, the arts, technology, education, and the humanities. Participants will engage with theoretical, applied, and research-driven approaches that reframe the responsibility of design in addressing today's global challenges. The program is structured around six key thematic pillars, including diversity and inclusion, human well-being, and the impact of emerging technologies. The successful realisation of this global initiative is made possible through the strategic support of CUD's key partners in the UAE. In alignment with the nation's vision for innovation, sustainability, and global leadership in design, Canadian University Dubai is proud to collaborate with Dubai Economy and Tourism as destination partners, RIBA Gulf Chapter, SEE Institute, and Dubai Holding Entertainment. Their contribution will be instrumental in shaping the scope, reach, and impact of the 2026 Cumulus Conference on both a regional and international scale. Mr. Massimo Imparato, Dean of the School of Architecture and Interior Design at CUD, commented: 'We are honoured to be selected as hosts of this influential gathering that challenges us to radically reimagine the systems, tools, and narratives that define design disciplines. Dubai is a city that embodies the urgency and aspiration of future-making and offers an exceptional backdrop for this global conversation.' Eija Salmi, Secretary General, speaking on behalf of the Cumulus Association, added: 'Cumulus has actively sought to expand its reach to increase accessibility and promote inclusivity. Dubai, an ideal bridge between Africa and Asia, and a living platform of future-driven innovation, was chosen in this spirit.' Founded in 1990, the Cumulus Association is the only global network dedicated to education and research in art, design, and media. It encompasses over 395 member institutions across 71 countries and is mission-driven to foster exchange, collaboration, and advancement in design thought leadership. The 2026 Cumulus Dubai Conference will be curated in collaboration with a distinguished scientific committee composed of academics and industry professionals from the UAE and around the world
Gulf Today
02-07-2025
- Business
- Gulf Today
Canadian University Dubai to host summit
The 5-day global summit to bring global leaders in the fields of art, design, and media education will be held at Canadian University Dubai (CUD) after it was officially selected to host the prestigious 2026 Cumulus Conference. The five-day global summit will take place in November 2026 under the transformative theme: 'Design(ed) Visions of Tomorrow | The Future of Human Condition' spearheaded by the University's School of Architecture and Interior Design. The 2026 Cumulus Dubai Conference will bring together international designers, educators, and researchers to reimagine the role of design in shaping regenerative, inclusive, and ethically driven futures. The summit will explore how design can serve as a catalyst for rethinking human life and living systems across physical, social, cultural, and ecological dimensions. Massimo Imparato, Dean of the School of Architecture and Interior Design at CUD, commented: 'We are honoured to be selected as hosts of this influential gathering that challenges us to radically reimagine the systems, tools, and narratives that define design disciplines. Dubai is a city that embodies the urgency and aspiration of future-making and offers an exceptional backdrop for this global conversation.' Eija Salmi, Secretary General, speaking on behalf of the Cumulus Association, added: 'Cumulus has actively sought to expand its reach with the aim of increasing accessibility and promoting inclusivity. Dubai, an ideal bridge between Africa and Asia, and a living platform of future-driven innovation, was chosen in this spirit.' According to the details, the conference will feature an interdisciplinary series of high-level panel discussions, exhibitions, hands-on workshops, and collaborative think tanks that will span the realms of architecture, the arts, technology, education, and humanities. Participants will engage with theoretical, applied, and research-driven approaches that reframe the responsibility of design in addressing today's global challenges. The programme is structured around six key thematic pillars, including diversity and inclusion, human well-being, and the impact of emerging technologies. The successful realisation of this global initiative is made possible through the strategic support of CUD's key partners in the UAE. In alignment with the nation's vision for innovation, sustainability, and global leadership in design, Canadian University Dubai is proud to collaborate with Dubai Economy and Tourism as destination partners, RIBA Gulf Chapter, SEE Institute, and Dubai Holding Entertainment. Their contribution will be instrumental in shaping the scope, reach, and impact of the 2026 Cumulus Conference on both a regional and international scale. Founded in 1990, the Cumulus Association is the only global network dedicated to education and research in art, design, and media. It encompasses over 395 member institutions across 71 countries, with a mission to foster exchange, collaboration, and advancement in design thought leadership.
Yahoo
17-06-2025
- Health
- Yahoo
FILAMENT HEALTH ENTERS INTO EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF ALABAMA AT BIRMINGHAM FOR DATA FROM A CLINICAL TRIAL OF PSILOCYBIN FOR THE TREATMENT OF COCAINE USE DISORDER
The data supports Filament's PEX010 drug development program targeting stimulant use disorders PEX010 is a first-in-class botanical psilocybin drug candidate currently under investigation in 52 clinical trials worldwide for 14 mental health indications VANCOUVER, BC, June 17, 2025 /CNW/ - Filament Health Corp. (OTC: FLHLF) ("Filament" or the "Company"), a clinical–stage natural psychedelic drug development company, today announced that it has entered into an exclusive global license agreement with the University of Alabama at Birmingham (UAB) for intellectual property related to a recently completed Phase 2 placebo-controlled clinical trial of psilocybin as a treatment for cocaine use disorder (CUD). The study investigated the safety and efficacy of a single-dose of psilocybin compared to placebo comparator in 40 adult patients with severe CUD. The trial was led by Principal Investigator Peter Hendricks, Ph.D., University Professor and Heersink Endowed Chair of Psychiatry at the UAB Department of Psychiatry and Behavioral Neurobiology, and a globally recognized expert in psychedelic-assisted therapies for addiction. "The results of the study demonstrated that psilocybin was well-tolerated and that a single dose resulted in a significant and durable reduction in cocaine use among people with CUD who were representative of cocaine users from the Deep South region of the United States. This is notable as most psychedelic trials fail to recruit participants representative of the population of those who could benefit from care.," said Dr. Hendricks. "We expect to have our data published in a peer-reviewed journal later this year and are excited to contribute to the science and possibly help bring to the clinic a promising treatment for cocaine and other stimulant use disorders in the future." Filament has obtained rights to access and use the data, know-how, and associated intellectual property from the clinical study, in furtherance of the Company's own proprietary development programs in stimulant use disorders. The partnership will also enable Dr. Hendricks to serve as an advisor to Filament Health and to advance research into other substance use conditions. "This agreement marks an important step in our mission to advance PEX010 and our other programs for the treatment of patients with stimulant use disorders," said Benjamin Lightburn, Co-Founder and Chief Executive Officer of Filament. "We are a leading developer of psychedelic drug candidates for substance use disorders and other mental health conditions. The positive data from Dr. Hendricks' trial, as well as his knowledge of clinical practices and ongoing counsel, will be significant assets in facilitating the advancement of our research." ABOUT FILAMENT HEALTH (OTC:FLHLF)Filament Health is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament's platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines for clinical development. We are paving the way with the first-ever natural psychedelic drug candidates. Learn more at and on Twitter, Instagram, and LinkedIn. FORWARD LOOKING INFORMATIONCertain statements and information contained in this press release and the documents referred to herein may constitute "forward–looking statements" and "forward–looking information," respectively, under Canadian securities legislation. Generally, forward–looking information can be identified by the use of forward–looking terminology such as, "expect", "anticipate", "continue", "estimate", "may", "will", "should", "believe", "intends", "forecast", "plans", "guidance" and similar expressions are intended to identify forward–looking statements or information. The forward–looking statements are not historical facts, but reflect the current expectations of management of Filament regarding future results or events and are based on information currently available to them. Certain material factors and assumptions were applied in providing these forward–looking statements. Forward–looking statements regarding the Company are based on the Company's estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of Filament to be materially different from those expressed or implied by such forward–looking statements or forward–looking information, including the timing and results of clinical trials, the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholders approvals; the ability of the parties to satisfy, in a timely manner, the other conditions to the completion of the proposed business combination; other expectations and assumptions concerning the transactions contemplated in the proposed business combination; the available funds of the parties and the anticipated use of such funds; the availability of financing opportunities; legal and regulatory risks inherent in the psychedelic drug development industry; risks associated with economic conditions, dependence on management and currency risk; risks relating to U.S. regulatory landscape; risks relating to anti-money laundering laws and regulation; other governmental and environmental regulation; public opinion and perception of the psychedelic drug development industry; risks related to the economy generally; risk of litigation; conflicts of interest; risks relating to certain remedies being limited and the difficulty of enforcement of judgments and effect service outside of Canada; and risks related to future acquisitions or dispositions. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward– looking statements and forward–looking information. Filament will not update any forward–looking statements or forward–looking information that are incorporated by reference herein, except as required by applicable securities laws. SOURCE Filament Health Corp. View original content to download multimedia: Sign in to access your portfolio
